Literature DB >> 15621680

Celecoxib incorporated chitosan microspheres: in vitro and in vivo evaluation.

Hetal Thakkar1, R K Sharma, A K Mishra, Krishna Chuttani, R S R Murthy.   

Abstract

Recently, considerable interest has been focussed on the use of biodegradable polymers for specialized applications such as controlled release of drug formulations; meanwhile, microsphere drug delivery systems using various kinds of biodegradable polymers have been studied extensively during the past two decades. In the present investigation, it was aimed to prepare microsphere formulations of celecoxib using a natural polymer, chitosan as a carrier for intra-articular administration to extend the retention of the drug in the knee joint. Microsphere formulations were evaluated in vitro for particle size, entrapment efficiency, surface morphology and in vitro drug release. For in vivo studies, (99m)Technetium- labeled glutathione was used as a radiopharmaceutical to demonstrate arthritic lesions by gamma scintigraphy. Evaluation of arthritic lesions post therapy in rats showed a significant difference (P < 0.005) in the group treated with celecoxib solution compared to the group treated with celecoxib loaded chitosan microspheres.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15621680     DOI: 10.1080/10611860400010630

Source DB:  PubMed          Journal:  J Drug Target        ISSN: 1026-7158            Impact factor:   5.121


  9 in total

1.  Synthesis and characterization of silk fibroin microparticles for intra-articular drug delivery.

Authors:  Timothy K Mwangi; Robby D Bowles; David M Tainter; Richard D Bell; David L Kaplan; Lori A Setton
Journal:  Int J Pharm       Date:  2015-02-24       Impact factor: 5.875

2.  Intra-articular clearance of labeled dextrans from naive and arthritic rat knee joints.

Authors:  Timothy K Mwangi; Ian M Berke; Eduardo H Nieves; Richard D Bell; Samuel B Adams; Lori A Setton
Journal:  J Control Release       Date:  2018-05-26       Impact factor: 9.776

3.  The clearance and biodistribution of magnetic composite nanoparticles in healthy and osteoarthritic rat knees.

Authors:  Brittany D Partain; Mythreyi Unni; Carlos Rinaldi; Kyle D Allen
Journal:  J Control Release       Date:  2020-01-28       Impact factor: 9.776

4.  Formulation and development of di-dependent microparticulate system for colon-specific drug delivery.

Authors:  Mayur M Patel
Journal:  Drug Deliv Transl Res       Date:  2017-04       Impact factor: 4.617

5.  Developed meloxicam loaded microparticles for colon targeted delivery: Statistical optimization, physicochemical characterization, and in-vivo toxicity study.

Authors:  Syed Abdul Wasay; Syed Umer Jan; Muhammad Akhtar; Sobia Noreen; Rahman Gul
Journal:  PLoS One       Date:  2022-04-25       Impact factor: 3.752

Review 6.  Materials for pharmaceutical dosage forms: molecular pharmaceutics and controlled release drug delivery aspects.

Authors:  Heidi M Mansour; Minji Sohn; Abeer Al-Ghananeem; Patrick P Deluca
Journal:  Int J Mol Sci       Date:  2010-09-15       Impact factor: 5.923

7.  Applicability of a newly developed bioassay for determining bioactivity of anti-inflammatory compounds in release studies--celecoxib and triamcinolone acetonide released from novel PLGA-based microspheres.

Authors:  Hsiao-yin Yang; Maarten van Dijk; Ruud Licht; Michiel Beekhuizen; Mattie van Rijen; Martina Källrot Janstål; F Cumhur Öner; Wouter J A Dhert; Detlef Schumann; Laura B Creemers
Journal:  Pharm Res       Date:  2014-08-28       Impact factor: 4.200

Review 8.  Progress in intra-articular therapy.

Authors:  Christopher H Evans; Virginia B Kraus; Lori A Setton
Journal:  Nat Rev Rheumatol       Date:  2013-11-05       Impact factor: 20.543

9.  Chitosan-hyaluronate hybrid gel intraarticular injection delays osteoarthritis progression and reduces pain in a rat meniscectomy model as compared to saline and hyaluronate treatment.

Authors:  Shachar Patchornik; Edward Ram; Noah Ben Shalom; Zvi Nevo; Dror Robinson
Journal:  Adv Orthop       Date:  2012-05-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.